CVS rises on earnings beat, guidance raise

CVS Health rose in premarket trading after it reported earnings that crushed Wall Street estimates and raised its full-year outlook.

The company reported adjusted earnings per share of $1.81, compared to the $1.46 analysts polled by FactSet were expecting. It also reported revenue of $98.9 billion, higher than the $94.5 billion the Street was anticipating.

CVS now expects to report adjusted earnings per share between $6.30 and $6.40 for 2025, up from between $6.00 to $6.20. That floor is higher than the $6.12 analysts are currently pricing in.

The company put the rosy earnings report down to strength in its insurance and retail businesses, which offset a decline in its health services segment.

Shares rose more than 7% in premarket trading and are up more than 40% since the start of the year.